-
2024-520050-38-00
5
2025-09-18
Extensive stage small cell lung cancer (ES-SCLC). S
-
2024-517143-31-00
4
2025-07-18
Autosomal Dominant Polycystic Kidney Disease
-
2023-505601-16-00
5
2025-04-22
Chronic Migraine
-
2024-512180-31-00
4
2025-03-14
Oligometastatic renal cell carcinoma
-
2024-516316-13-00
4
2025-01-21
Merkel cell carcinoma without metastases in other organs and surgicall
-
2024-515070-28-00
5
2024-12-23
HIV Infections
-
2024-518611-18-00
4
2024-12-03
Chemotherapy-induced cardiotoxicity in breast cancer
-
2024-513539-25-00
4
2024-11-22
Type 2 Diabetes Mellitus
-
2023-505989-29-00
5
2024-11-21
Extensive stage small cell lung cancer (ES-SCLC)
-
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
-
2023-506049-52-00
4
2024-10-28
Follicular lymphoma
-
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
-
2024-512676-36-00
10
2024-10-09
Langerhans Cell Histiocytosis
-
2023-504753-12-00
5
2024-10-01
Lung Cancer, Non-Small Cell
-
2023-505739-12-01
5
2024-09-30
Chronic Inducible Urticaria (CINDU)
-
2023-507851-31-00
5
2024-09-23
Immunoglobulin A Nephropathy (IgAN)
-
2024-510908-37-00
5
2024-08-28
KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (
-
2023-509762-38-00
5
2024-08-01
Respiratory Syncytial Virus Infections
-
2023-509947-29-00
4
2024-07-18
Anemia in patients with very low, low or intermediate risk myelodyspla
-
2023-503666-23-00
5
2024-06-07
Neovascular age-related macular degeneration
-
2023-503755-10-00
5
2024-05-17
Splenic marginal zone lymphoma
-
2023-503231-17-00
5
2024-04-26
Unresectable Pleural Mesothelioma
-
2023-503357-35-00
4
2024-03-20
Non-small Cell Lung Cancer (NSCLC)
-
2023-504816-14-00
5
2024-03-08
Endometrial cancer